Home›Stock Screener›Sudeep Pharma›Quarterly Results

Sudeep Pharma Quarterly Results

Latest Quarter Net Profit
₹49 Cr
QMar 2026
Quarterly Results

Sudeep Pharma quarterly results. In Mar 2026, Sudeep Pharma (SUDEEPPHRM) reported revenue ₹189 Cr and net profit ₹49 Cr — revenue +17.4% YoY. For annual financials, live price and key ratios, visit SUDEEPPHRM share price.

SUDEEPPHRM Quarterly Results — Revenue, Profit & EPS Highlights

Sudeep Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check SUDEEPPHRM market cap trends to track the company's total market size over time.

  • Revenue of ₹189 Cr in Mar 2026 (+15.2% vs Jun 2026, +17.4% vs Mar 2025)
  • Net Profit of ₹49 Cr in Mar 2026 (+19.5% vs Jun 2026, +11.4% vs Mar 2025)
  • EBITDA of ₹69 Cr in Mar 2026 (+15.0% vs Jun 2026)
  • Operating Margin of 34.0% in Mar 2026 (-1.0pp vs Jun 2026)
  • Earnings Per Share of ₹4.38 in Mar 2026 (+22.0% vs Jun 2026)

Sudeep Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS

SUDEEPPHRM quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 189 164 173 161 130 15.2% 17.4%
Net Profit (₹ Cr) 49 41 47 44 31 - -
EBITDA (₹ Cr) 69 60 66 63 49 - -
EPS (₹) 4.38 3.59 4.20 4.07 2.84 - -
Operating Margin (%) 34.0% 35.0% 34.0% 37.0% 35.0% - -

SUDEEPPHRM Share Price Trend — 1-Year Movement Across Quarterly Results

Sudeep Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Review SUDEEPPHRM price earnings ratio to evaluate earnings-based valuation against sector peers.

Profitability Ratios

Profit Margin 25.9%
EBITDA Margin 36.5%
Operating Margin 34.0%
ROE (Annual) 21.8%

Balance Sheet Highlights

Total Assets ₹1,175 Cr
Total Equity ₹898 Cr
Current Assets ₹624 Cr
Current Liabilities ₹75 Cr

Cash Flow Analysis

Operating Cash Flow ₹70 Cr
Investing Cash Flow ₹-327 Cr
Financing Cash Flow ₹247 Cr
Net Cash Flow ₹-10 Cr

Current Market Data

Current Price ₹1173.40
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 161
Sept 2025 173
Jun 2026 164
Mar 2026 189

Net Profit Trend (₹ Cr)

Mar 2025 44
Sept 2025 47
Jun 2026 41
Mar 2026 49

Operating Margin Trend (%)

Mar 2025 37.0%
Sept 2025 34.0%
Jun 2026 35.0%
Mar 2026 34.0%

SUDEEPPHRM vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Sudeep Pharma latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores